FeesSafety
Pluang+

Nanox to release Q3 2026 financial results on Nov 25 with CEO call at 8:30 a.m. ET

Company Fundamentals
16 Nov 2026, 23:05 WIB
GlobeNewsWire
View Source
Neutral
Nanox to release Q3 2026 financial results on Nov 25 with CEO call at 8:30 a.m. ET

Nanox Imaging Ltd will announce its financial results for the third quarter ended September 30, 2026, on November 25 before the market opens. CEO Erez Meltzer will host a conference call at 8:30 a.m. ET to discuss the results and provide a business update. Nanox is known for its innovative medical imaging technology that integrates AI, cloud solutions, and remote radiology to improve healthcare access and preventive care. Investors and interested parties can register for the call or watch the live webcast via links on Nanox's website.

Nanox's upcoming Q3 2026 financial results announcement provides context for health sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 17, 2026 03:31 WIB: out of 150 priced health-sector US stocks, 31 rose and 118 fell. Notable movers include HRTX at USD 0.29 with a 1-day change of -6.57% and a typical hold time on Pluang of 40 days, SLS at USD 7.36 with a -6.42% change and 96% buy order activity, and ARWR at USD 44.78 with a -6.28% change and a typical hold time of 17 days.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
2 hours ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
2 hours ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
3 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
4 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App